NO20000216L - Piperazinderivater - Google Patents
PiperazinderivaterInfo
- Publication number
- NO20000216L NO20000216L NO20000216A NO20000216A NO20000216L NO 20000216 L NO20000216 L NO 20000216L NO 20000216 A NO20000216 A NO 20000216A NO 20000216 A NO20000216 A NO 20000216A NO 20000216 L NO20000216 L NO 20000216L
- Authority
- NO
- Norway
- Prior art keywords
- piperazine derivatives
- piperazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19730989A DE19730989A1 (de) | 1997-07-18 | 1997-07-18 | Piperazin-Derivate |
PCT/EP1998/003956 WO1999003855A1 (de) | 1997-07-18 | 1998-06-29 | Piperazin-derivate |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20000216D0 NO20000216D0 (no) | 2000-01-17 |
NO20000216L true NO20000216L (no) | 2000-01-17 |
Family
ID=7836208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000216A NO20000216L (no) | 1997-07-18 | 2000-01-17 | Piperazinderivater |
Country Status (23)
Country | Link |
---|---|
US (1) | US6251908B1 (no) |
EP (1) | EP0998474B1 (no) |
JP (1) | JP2001510193A (no) |
KR (1) | KR100528684B1 (no) |
CN (1) | CN1093127C (no) |
AR (1) | AR010932A1 (no) |
AT (1) | ATE353326T1 (no) |
AU (1) | AU731332B2 (no) |
BR (1) | BR9810607A (no) |
CA (1) | CA2296687A1 (no) |
DE (2) | DE19730989A1 (no) |
ES (1) | ES2281131T3 (no) |
HU (1) | HUP0002718A3 (no) |
ID (1) | ID24663A (no) |
MY (1) | MY132794A (no) |
NO (1) | NO20000216L (no) |
PL (1) | PL191078B1 (no) |
RU (1) | RU2194048C2 (no) |
SK (1) | SK352000A3 (no) |
TW (1) | TW425398B (no) |
UA (1) | UA59407C2 (no) |
WO (1) | WO1999003855A1 (no) |
ZA (1) | ZA986390B (no) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4919565B2 (ja) * | 1999-08-23 | 2012-04-18 | アボツト・ヘルスケア・プロダクツ・ベー・ブイ | 新規なフェニルピペラジン |
PL204331B1 (pl) * | 2000-11-14 | 2010-01-29 | Merck Patent Gmbh | Zastosowanie związków będących kombinowanymi selektywnymi inhibitorami wychwytu zwrotnego serotoniny (5-HT)(SSRIs) i agonistami receptora 5-HT1A do wytwarzania leków weterynaryjnych |
AR032712A1 (es) | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
DE10112151A1 (de) * | 2001-03-14 | 2002-09-19 | Merck Patent Gmbh | Substituierte Benzofuran-2-carbonsäureamide |
EP1408976B3 (en) * | 2001-07-20 | 2010-08-25 | Psychogenics Inc. | Treatment for attention-deficit hyperactivity disorder |
US20030045449A1 (en) * | 2001-08-15 | 2003-03-06 | Pfizer, Inc. | Pharmaceutical combinations for the treatment of neurodegenerative diseases |
DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
DE10259244A1 (de) * | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | N-(Indolethyl-)cycloamin-Verbindungen |
DE10305739A1 (de) | 2003-02-11 | 2004-08-19 | Merck Patent Gmbh | Benzofuranderivate |
DE10315285A1 (de) * | 2003-04-04 | 2004-10-14 | Merck Patent Gmbh | Chromenonindole |
GT200600414A (es) * | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
US9066903B2 (en) | 2006-02-28 | 2015-06-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Pharmacological treatment of Parkinson's disease |
US9090638B2 (en) | 2008-04-17 | 2015-07-28 | Thomas Daly | Biological buffers with wide buffering ranges |
US8822728B2 (en) | 2008-04-17 | 2014-09-02 | Thomas Daly | Biological buffers with wide buffering ranges |
US7939659B2 (en) * | 2008-04-17 | 2011-05-10 | Thomas Daly | Biological buffers with wide buffering ranges |
US8334402B2 (en) * | 2008-04-17 | 2012-12-18 | Thomas Daly | Biological buffers with wide buffering ranges |
US8034951B2 (en) * | 2008-04-17 | 2011-10-11 | Thomas Daly | Biological buffers with wide buffering ranges |
US9447310B2 (en) | 2008-04-17 | 2016-09-20 | Thomas P. Daly | Biological buffers with wide buffering ranges |
US8519141B2 (en) | 2008-04-17 | 2013-08-27 | Thomas Daly | Biological buffers with wide buffering ranges |
US7635791B2 (en) * | 2008-04-17 | 2009-12-22 | Tpat Ip Llc | Biological buffers with wide buffering ranges |
US20170313920A1 (en) | 2010-10-06 | 2017-11-02 | Thomas P. Daly | Biological Buffers with Wide Buffering Ranges |
JP5792061B2 (ja) * | 2008-05-30 | 2015-10-07 | サイコジェニックス・インコーポレーテッドPsychogenics Inc. | 神経及び精神障害の治療法 |
CN102740881A (zh) | 2009-05-12 | 2012-10-17 | 特兰斯吉恩股份有限公司 | 正痘病毒产生和纯化方法 |
CN102206214B (zh) * | 2011-04-07 | 2014-03-12 | 华中科技大学 | 苯并吡喃酮类衍生物及其应用 |
US9475754B2 (en) | 2011-10-06 | 2016-10-25 | Thomas P. Daly | Biological buffers with wide buffering ranges |
NZ716487A (en) * | 2012-05-23 | 2017-01-27 | Nerviano Medical Sciences Srl | Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide |
CN104337812B (zh) | 2013-07-29 | 2018-09-14 | 广东东阳光药业有限公司 | 取代的杂芳基化合物及其使用方法和用途 |
CN105418506B (zh) * | 2014-09-19 | 2018-04-24 | 上海医药工业研究院 | 乙酰苄胺哌嗪类衍生物及其作为脑神经保护剂的应用 |
CN106243088B (zh) | 2015-06-03 | 2019-01-04 | 广东东阳光药业有限公司 | 取代的哌嗪化合物及其使用方法和用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB146691A (en) * | 1919-05-29 | 1920-07-15 | William Herbert Tripp | Apparatus for indicating and recording side drift or leeway of aircraft |
FR2189027B1 (no) | 1972-06-21 | 1976-03-05 | Leurquin Laboratoires Fr | |
DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
NZ333870A (en) * | 1996-07-26 | 2000-08-25 | Nissan Chemical Ind Ltd | 4-amino substituted chroman derivatives |
ES2206963T3 (es) * | 1997-07-25 | 2004-05-16 | H. Lundbeck A/S | Derivados de indol y de 2,3-dihidroindol, su preparacion y uso. |
-
1997
- 1997-07-18 DE DE19730989A patent/DE19730989A1/de not_active Withdrawn
-
1998
- 1998-06-29 CN CN98807377A patent/CN1093127C/zh not_active Expired - Fee Related
- 1998-06-29 HU HU0002718A patent/HUP0002718A3/hu unknown
- 1998-06-29 AU AU87302/98A patent/AU731332B2/en not_active Ceased
- 1998-06-29 DE DE59813899T patent/DE59813899D1/de not_active Expired - Fee Related
- 1998-06-29 EP EP98938671A patent/EP0998474B1/de not_active Expired - Lifetime
- 1998-06-29 AT AT98938671T patent/ATE353326T1/de not_active IP Right Cessation
- 1998-06-29 PL PL338075A patent/PL191078B1/pl not_active IP Right Cessation
- 1998-06-29 US US09/462,468 patent/US6251908B1/en not_active Expired - Fee Related
- 1998-06-29 BR BR9810607-4A patent/BR9810607A/pt not_active Application Discontinuation
- 1998-06-29 UA UA2000020920A patent/UA59407C2/uk unknown
- 1998-06-29 KR KR10-2000-7000522A patent/KR100528684B1/ko not_active IP Right Cessation
- 1998-06-29 ES ES98938671T patent/ES2281131T3/es not_active Expired - Lifetime
- 1998-06-29 RU RU2000102920/04A patent/RU2194048C2/ru not_active IP Right Cessation
- 1998-06-29 JP JP2000503079A patent/JP2001510193A/ja active Pending
- 1998-06-29 SK SK35-2000A patent/SK352000A3/sk unknown
- 1998-06-29 WO PCT/EP1998/003956 patent/WO1999003855A1/de not_active Application Discontinuation
- 1998-06-29 ID IDW20000151A patent/ID24663A/id unknown
- 1998-06-29 CA CA002296687A patent/CA2296687A1/en not_active Abandoned
- 1998-07-16 MY MYPI98003262A patent/MY132794A/en unknown
- 1998-07-17 TW TW087111694A patent/TW425398B/zh not_active IP Right Cessation
- 1998-07-17 ZA ZA986390A patent/ZA986390B/xx unknown
- 1998-07-17 AR ARP980103491A patent/AR010932A1/es unknown
-
2000
- 2000-01-17 NO NO20000216A patent/NO20000216L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010021957A (ko) | 2001-03-15 |
DE19730989A1 (de) | 1999-01-21 |
ZA986390B (en) | 1999-05-24 |
EP0998474B1 (de) | 2007-02-07 |
AR010932A1 (es) | 2000-07-12 |
SK352000A3 (en) | 2000-06-12 |
UA59407C2 (uk) | 2003-09-15 |
AU731332B2 (en) | 2001-03-29 |
HUP0002718A2 (hu) | 2001-10-28 |
KR100528684B1 (ko) | 2005-11-15 |
PL338075A1 (en) | 2000-09-25 |
TW425398B (en) | 2001-03-11 |
DE59813899D1 (de) | 2007-03-22 |
ES2281131T3 (es) | 2007-09-16 |
NO20000216D0 (no) | 2000-01-17 |
ATE353326T1 (de) | 2007-02-15 |
BR9810607A (pt) | 2000-07-11 |
CN1093127C (zh) | 2002-10-23 |
HUP0002718A3 (en) | 2001-11-28 |
AU8730298A (en) | 1999-02-10 |
ID24663A (id) | 2000-07-27 |
JP2001510193A (ja) | 2001-07-31 |
CN1264379A (zh) | 2000-08-23 |
MY132794A (en) | 2007-10-31 |
US6251908B1 (en) | 2001-06-26 |
WO1999003855A1 (de) | 1999-01-28 |
RU2194048C2 (ru) | 2002-12-10 |
EP0998474A1 (de) | 2000-05-10 |
PL191078B1 (pl) | 2006-03-31 |
CA2296687A1 (en) | 1999-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE353326T1 (de) | Piperazin-derivate | |
BR9712037A (pt) | Derivados de piperazina | |
DK1005446T3 (da) | N-aroylphenylalaninderivater | |
ATE235220T1 (de) | Resorcinderivate | |
ID22781A (id) | Turunan-turunan nikotinamida | |
DE69817186D1 (de) | Diaminorhodamin-derivate | |
NO20010193L (no) | Tiobenzimidazol-derivater | |
ATE236136T1 (de) | Benzosulfonderivate | |
PT915088E (pt) | Derivados de d-prolina | |
EE9800219A (xx) | Uued 19-nor-pregneeni derivaadid | |
ATE259810T1 (de) | Phenyl-xanthinderivate | |
NO20010514L (no) | Aminometylkarboksylsyre-derivater | |
ATE278695T1 (de) | Piperidinderivate | |
ATE255098T1 (de) | Substituierte chromanderivate | |
ATE321042T1 (de) | Piperazin-derivate | |
PT1003719E (pt) | Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida | |
PT1027362E (pt) | Derivados de cetolidos 2-halogeno-6-o-substituidos | |
DE69841086D1 (de) | 5-Deoxy-Cytidin-Derivate | |
ATE255099T1 (de) | Substituierte chromanderivate | |
DK1115716T3 (da) | 2-phenylpyran-4-on-derivater | |
ATE233253T1 (de) | Chromanderivate | |
DK1134219T3 (da) | Cucloalkylsubstituerede aminomethylpyrrolidinderivater | |
ATE292632T1 (de) | Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate | |
DE69828780D1 (de) | Amidinocamptpthecin-derivate | |
NO981495L (no) | Fenoksymetylpiperidin-derivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |